松芝股份(002454.SZ)擬3498.45萬元購買博士朗電子30%股份
格隆匯 3 月 25日丨松芝股份(002454.SZ)公佈,為了進一步推動公司汽車空調核心零部件業務的發展,公司擬使用自有資金3498.45萬元向陳武宏、李財宏、周鳴方購買南京博士朗電子技術有限公司(“博士朗電子”)30%的股份。
博士朗電子及其子公司南京博士朗新能源科技有限公司(“博士朗新能源”)是松芝股份下屬負責汽車空調核心零部件的研發、生產和銷售板塊。此次收購完成後,博士朗電子和博士朗新能源將成為公司的全資子公司,有利於公司集中各方面資源加大對汽車空調核心零部件的研發、生產和銷售力度,擴大該板塊的業務發展,培育公司的關鍵零部件的核心能力,從而提高公司熱管理相關產品的市場競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.